Shelter Pharma Limited (BOM:543963)
India · Delayed Price · Currency is INR 27.07
+0.17 (0.63%)
At close: Jul 27, 2026
Shelter Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 10.79 | 34.2 | 50.4 | 4.29 | 1 |
Cash & Short-Term Investments | 10.79 | 34.2 | 50.4 | 4.29 | 1 |
Cash Growth | -68.45% | -32.14% | 1076.13% | 328.07% | -72.98% |
Accounts Receivable | 118.07 | 94.75 | 88.5 | 81.95 | 16.06 |
Other Receivables | - | - | - | - | 0.84 |
Receivables | 118.07 | 94.75 | 88.5 | 81.95 | 16.89 |
Inventory | 244.39 | 128.95 | 99.29 | 79.65 | 56.74 |
Prepaid Expenses | - | - | 0 | 0.01 | 0.01 |
Other Current Assets | 177.24 | 74.89 | 59 | 21.27 | 23.68 |
Total Current Assets | 550.49 | 332.79 | 297.19 | 187.16 | 98.32 |
Property, Plant & Equipment | 66.83 | 59.51 | 35.71 | 18.45 | 20.05 |
Long-Term Investments | 6.76 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Intangible Assets | 4.59 | 0.1 | 0.09 | - | - |
Long-Term Deferred Tax Assets | 0.01 | 0.32 | 0.36 | - | - |
Other Long-Term Assets | 213.66 | 90.63 | 45.81 | 8.87 | 10.02 |
Total Assets | 842.33 | 483.36 | 379.15 | 214.48 | 128.39 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 12.54 | 12.51 | 7.14 | 4.68 | 3.23 |
Accrued Expenses | - | 1.75 | 1.25 | 0.73 | 0.05 |
Short-Term Debt | 2.67 | 1.13 | 0.04 | 13.04 | 0.38 |
Current Portion of Long-Term Debt | - | - | - | - | 0.29 |
Current Income Taxes Payable | - | 30.02 | 5.66 | 17.79 | 6.5 |
Current Unearned Revenue | - | - | - | 25 | - |
Other Current Liabilities | 54.8 | 0.88 | 0.66 | 1.24 | 26.63 |
Total Current Liabilities | 70 | 46.29 | 14.75 | 62.48 | 37.07 |
Long-Term Debt | 5.35 | 9.32 | 5.73 | 4.8 | 0.65 |
Pension & Post-Retirement Benefits | 0.67 | 0.55 | 0.51 | 0.49 | 0.38 |
Long-Term Deferred Tax Liabilities | - | - | - | 1.23 | 1.01 |
Other Long-Term Liabilities | - | -0 | -0 | -0 | -0 |
Total Liabilities | 76.01 | 56.15 | 20.99 | 69 | 39.11 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 166.12 | 115.6 | 115.6 | 77.44 | 4.84 |
Additional Paid-In Capital | - | 122.11 | 122.11 | 39.96 | 39.96 |
Retained Earnings | - | 180.08 | 111.03 | 18.67 | 35.07 |
Comprehensive Income & Other | 600.2 | 9.42 | 9.42 | 9.42 | 9.42 |
Shareholders' Equity | 766.32 | 427.21 | 358.16 | 145.49 | 89.29 |
Total Liabilities & Equity | 842.33 | 483.36 | 379.15 | 214.48 | 128.39 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 8.01 | 10.44 | 5.77 | 17.84 | 1.31 |
Net Cash (Debt) | 2.78 | 23.76 | 44.62 | -13.56 | -0.31 |
Net Cash Growth | -88.30% | -46.76% | - | - | - |
Net Cash Per Share | 0.16 | 2.06 | 3.86 | -1.75 | -0.04 |
Filing Date Shares Outstanding | 15.91 | 11.56 | 11.56 | 11.56 | 7.74 |
Total Common Shares Outstanding | 15.91 | 11.56 | 11.56 | 7.74 | 7.74 |
Working Capital | 480.49 | 286.5 | 282.44 | 124.68 | 61.25 |
Book Value Per Share | 48.17 | 36.96 | 30.98 | 18.79 | 11.53 |
Tangible Book Value | 761.73 | 427.11 | 358.07 | 145.49 | 89.29 |
Tangible Book Value Per Share | 47.88 | 36.95 | 30.98 | 18.79 | 11.53 |
Buildings | - | - | 40.19 | 30.69 | 25.14 |
Machinery | - | - | 10.58 | 6.56 | 6.52 |
Construction In Progress | - | - | 6.18 | - | 5.55 |